A small, hidden difference in how the body processes caffeine appears to shape diabetes risk in ways everyday habits fail to explain.
The signal does not come from the coffee cup, but from what happens after caffeine enters the bloodstream.
What the genes suggest
Genetic differences that slow the body’s breakdown of caffeine were associated with about 19 percent lower odds of type 2 diabetes, independent of coffee intake.
Using DNA as a guide, researchers at the Karolinska Institutet (KI) looked past coffee cups and focused on caffeine levels inside the body.
Dr. Susanna C. Larsson led the work at KI and coordinated data analysis for this project. Her team studies how diet-related exposures and genetics combine to shape long-term risk for metabolic and heart disease.
The results put caffeine biology, rather than beverage habits, at the center of debates about weight and diabetes.
Brewing changes the biology
A review of long-term studies links coffee drinking with lower type 2 diabetes risk, even when caffeine varies.
Brewing method changes which coffee compounds reach the body, separate from caffeine.
“In previous studies it was found that coffee contributes to bad blood lipids which can increase the risk of cardiovascular diseases,” said Larsson.
That extra chemistry means coffee intake can look protective or harmful even when caffeine exposure stays the same.
How caffeine builds up
Caffeine levels in blood depend on both what you drink and how quickly your liver breaks it down.
The measured concentration sits in plasma, the liquid part of blood, and it stays higher when metabolism runs slowly.
A study linked common DNA variants to caffeine metabolites and showed that slow breakdown often leads to lower coffee intake.
That mismatch helps explain why drinking more coffee is not the same as having more caffeine circulating for hours.
A genetic shortcut for causality
Instead of tracking diets for decades, the team used Mendelian randomization – a genetic approach for cause-and-effect estimates.
They focused on two DNA variants tied to caffeine metabolism, which act like lifelong markers because genes stay fixed.
By comparing those variants with body fat, diabetes, and heart outcomes across large genetic databases, the analysis reduced confounding.
Even so, the method cannot prove what would happen if someone changed their daily caffeine dose or source.
Small changes in body fat
The clearest signal showed up in adiposity, the amount of body fat, rather than in lean tissue or bone.
Higher genetically predicted caffeine concentration was linked to a small drop in BMI, equal to about 0.38 points.
The same genetic pattern matched about 1.3 lb (0.57 kg) less fat mass, while fat-free mass barely changed.
Short trials suggest caffeine can modestly reduce weight and fat mass, but genetics cannot replace controlled dosing studies.
Where diabetes risk moved
Evidence was strongest for diabetes, drawing on large international studies that track genetic links to disease.
Seeing the same pattern across datasets made the result more convincing.
A follow-up mediation analysis, estimating how one factor works through another, put 43 percent of the diabetes effect through BMI reduction.
The remaining share may involve other processes, such as changes in insulin response, but genetic data cannot trace those steps directly.
Heart outcomes stayed flat
Researchers also tested links to major heart and stroke problems, where past coffee studies have often disagreed.
Across coronary disease, irregular heart rhythm, heart failure, and stroke, the genetic signal did not show a clear pattern.
The null result could mean caffeine has little heart effect, or that risk differs at low and high levels.
Either way, the study gives stronger support for a weight and diabetes link than for a cardiovascular one.
Caffeine still has limits
The U.S. Food and Drug Administration (FDA) cites 400 mg a day as not generally linked to negative effects for most adults.
Because caffeine blocks adenosine, a brain chemical that promotes sleepiness, late-day intake can stretch wakefulness into the night.
The FDA estimates seizures can appear after rapid doses around 1,200 mg, especially with pure powders that are easy to overmeasure.
For any health study, caffeine needs to stay inside realistic ranges, and sugary drinks can cancel metabolic benefits with extra calories.
Study limitations and next steps
Any link from genetics to health still leaves a gap between a blood marker and a real-world drink choice.
These analyses assume the DNA variants affect disease only by changing caffeine levels – not by also nudging other habits.
Most participants came from European ancestry datasets, and the design could not test whether moderate and high exposure behave differently.
Future studies could track plasma caffeine directly over time and test controlled doses, while keeping sleep and heart rhythm under watch.
The genetics point to caffeine staying in the blood longer as a metabolic signal, not just a habit.
Coffee still brings many compounds and choices, so clearer answers will need long trials that separate caffeine from the rest.
The study is published in the journal BMJ Medicine.
—–
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–
